Incyte to Present at Upcoming Investor Conferences
Incyte announced its participation in several investor conferences throughout June 2021. Key events include the William Blair 41st Annual Growth Stock Conference on June 3, the BioPharma Sustainability Roundtable’s CEO Investor Forum on June 7, the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, and Guggenheim’s series on June 28. These presentations will be available for live webcast and replay at Investor.Incyte.com.
Incyte is a biopharmaceutical company focused on addressing unmet medical needs through innovative therapeutics.
- None.
- None.
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:
- William Blair 41st Annual Growth Stock Conference (Virtual) on Thursday, June 3, 2021 at 1:00 pm (EDT)
- BioPharma Sustainability Roundtable’s CEO Investor Forum on Monday, June 7, 2021 at 1:35 pm (EDT)
- Goldman Sachs 42nd Annual Global Healthcare Conference (Virtual) on Tuesday, June 8, 2021 at 8:00 am (EDT)
- Guggenheim’s “Biopharma’s Next Decade: Views from the Top on Global Strategy and Innovation” Series on Monday, June 28, 2021 at 11:00 am (EDT)
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005078/en/
FAQ
When is Incyte presenting at the William Blair Growth Stock Conference?
What are the key dates for Incyte's investor conferences in June 2021?
Is there a webcast available for Incyte's June presentations?